TopoDx
Atlanta, US · Founded 2024 · Georgia corporation · 1 known investors
Find your way into TopoDx
Rapid optical antimicrobial susceptibility testing platform
Founders & leadership
YP
Yogi PatelExecutive
Board
PY
Peter YunkerBoard director
DW
David WeissBoard director
Investors · 1
Portal Innovationslisted by Portal InnovationsChicago
How we know: Portal Innovations's portfolio page · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2025
▶$1.5MraisedSep 2025 · 10 investors · BiotechnologyRule 506(b)
▶$1.5MraisedSep 2025 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter YunkerDirector
- David WeissDirector
- Yogi PatelExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.5M
- Minimum investment
- $25K
- Proceeds to insiders
- $60K
- First sale
- Jul 2025
- Incorporated
- Corporation, Georgia, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does TopoDx do?
- Rapid optical antimicrobial susceptibility testing platform
- Who are TopoDx's investors?
- TopoDx's investors include Portal Innovations.
- How much funding has TopoDx raised?
- TopoDx has disclosed $1.5M raised across 1 round.
- Where is TopoDx headquartered?
- TopoDx is headquartered in Atlanta, US.
